Skip to content
DiaMonTech AG logo — Say goodbye to finger pricking!

DiaMonTech AG

Say goodbye to finger pricking!

Founded 2015 Germany Berlin, Germany 28 employees Non Equity Assistance Total: $18.20M Biotechnology, Health Care +1

General Information

Company Name DiaMonTech AG
Founded Year 2015
Location Germany Berlin, Germany
Founders / Decision Makers
Team member
Employees 28
Industries Biotechnology, Health Care, Sports
Funding Stage Non Equity Assistance
Business Model B2C, B2B, D2C
Revenue Model One Time Purchase, Licensing
Social

BounceWatch is an independent company data service, not affiliated with DiaMonTech AG. To contact DiaMonTech AG, visit diamontech.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DiaMonTech AG compare?

A PDF of DiaMonTech AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DiaMonTech AG soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DiaMonTech AG

DiaMonTech AG, a breakthrough player in the Biotechnology and Health Care industries, is making strides from its headquarters in Germany. Founded in 2015, the company has garnered attention for its innovative medical device that measures blood glucose levels non-invasively. With the slogan "Say goodbye to finger pricking!", DiaMonTech leverages a patented technology utilizing an invisible infrared light beam to quantify glucose molecules, providing painless and cost-effective diabetes management.

The significant impact of DiaMonTech's technology is underscored by the global diabetes challenge, affecting over 400 million individuals worldwide. By facilitating frequent monitoring akin to the ease of unlocking a phone, the company aims to enhance ongoing diabetes management— a feature that can potentially lead to fewer diabetes-related complications.

Recently, DiaMonTech secured a Non Equity Assistance investment on 29 May 2024 from MedTech Innovator, highlighting its continued traction and potential in transforming diabetes care globally.

Business keywords: Non-Invasive Technology, Blood Glucose Measurement, Diabetes Management, Laser Technology, Healthcare Innovation, MedTech Startup, Glucose Monitoring, Patient-Friendly Design, Precision Health, Diabetes Care Solutions, Sensor Technology, HealthTech, Infrared Technology, Pain-Free Testing

Services & Products

Development of non-invasive glucose monitoring devices
Integration of photothermal spectroscopy in medical technology
Mobile medical product design and miniaturization
Predictive data modeling for health applications
Biomedical device regulatory and certification processes

Target Customers

Individuals with Diabetes Healthcare Providers and Professionals Health-conscious Consumers Insurance Companies Smartwatch and Wearable Technology Companies

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MedTech Innovator
29 May 2024
Venture Round Undisclosed 1
Moll Family
07 Dec 2023
Venture Round €5.00M 4
IBB Ventures, Samsung Ventures +2
17 Feb 2022
Grant $400.00K 1
Pro FIT – project financing
10 Mar 2020
Debt Financing $800.00K 1
Pro FIT – project financing
10 Mar 2020
Series A €7.00M 2
IBB Ventures, BioVenture
09 Sep 2019
Seed Round €5.00M 3
IBB Ventures, Macnica +1
04 Sep 2018
Seed Round Undisclosed 1
Media Ventures
01 Jan 2017

DiaMonTech AG Alternatives & Competitors

View All Alternatives
DiaMonTech AG vs

A wearable device for non-invasive measurement of blood glucose concentration using spectrophotometr...

Seed
19 employees
Biotechnology, Hardware
DiaMonTech AG vs

Making life with diabetes easier

Debt Financing
65 employees
Biotechnology, Health Care
DiaMonTech AG vs

We are on a mission to make drug and health monitoring seamless.

Seed
3 employees
Health Care, Sports

FAQ About DiaMonTech AG

Say goodbye to finger pricking!
DiaMonTech AG was founded in 2015.
DiaMonTech AG is headquartered in Berlin, Germany.
DiaMonTech AG operates in Biotechnology, Health Care and Sports. Its work centres on Non-Invasive Technology, Blood Glucose Measurement, Diabetes Management and Laser Technology. Its customers include Individuals with Diabetes, Healthcare Providers and Professionals and Health-conscious Consumers.
DiaMonTech AG has a B2C, B2B and D2C business model. Its revenue comes from One Time Purchase and Licensing.
DiaMonTech AG has approximately 28 employees.
DiaMonTech AG has completed 8 funding rounds, raising a total of $18.20M. The latest funding stage is Non Equity Assistance.
DiaMonTech AG offers: Development of non-invasive glucose monitoring devices, Integration of photothermal spectroscopy in medical technology, Mobile medical product design and miniaturization, Predictive data modeling for health applications, Biomedical device regulatory and certification processes.
Top alternatives and competitors to DiaMonTech AG include GlucoActive Sp. z o.o., Intuity Medical, Inc., Voyage Labs (previously Medella Health), Transdermal Diagnostics Ltd, OptiScan Biomedical Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DiaMonTech AG and GlucoActive Sp. z o.o. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DiaMonTech AG, https://bouncewatch.com/company/diamontech, updated 6 August 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout